The shares of ) rose 3.3% on Tuesday. The company traded up to $33.90, and traded last at $33.85. The volume of 56,500 shares was down 51% compared to the session average of 116 034 shares. Stock had closed previously at $32.77.
Wall Street analysts forecast growth
Separately UBS Group reduced their target price for Koninklijke DSM in a research report on Friday, 6th January from EUR143.00 ($158.89), to EUR140.00. They also set a "buy" rating for the firm. The company has a moving average of $33.85 for the past 50 days and $33.07 for the last two hundred days. The debt-to equity ratio for the company is 0.30. Its quick ratio is 1.72, and its current ratio is 2.51.
About Koninklijke DSM
Koninklijke DSM N.V. is a science-based firm that engages in nutrition and health businesses, as well as sustainable living in the Netherlands and Switzerland. It also has operations in North America, Latin America and China. It is divided into three segments: Nutrition, Materials, and Innovation Center.
MarketBeat.com offers a FREE daily email newsletter